Repligen Corporation

Stock Chart, Company Information, and Scan Results

$119.51(as of Sep 11, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Repligen Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$119.51
Ticker SymbolRGEN
ExchangeNasdaq
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees1,778
CountyUSA
Market Cap$6,763.9M
EBIDTA126.5M
10-Day Moving Average120.56
P/E Ratio-488.42
20-Day Moving Average121.54
Forward P/E Ratio57.47
50-Day Moving Average121.10
Earnings per Share-0.25
200-Day Moving Average136.64
Profit Margin8.15%
RSI48.23
Shares Outstanding56.3M
ATR4.64
52-Week High182.52
Volume624,455
52-Week Low102.97
Most Recent Support Level117.18
Book Value2,061.7M
Most Recent Resistance Level125.31
P/B Ratio3.28
Upper Keltner131.99
P/S Ratio10.02
Lower Keltner111.10
Debt-to-Equity Ratio131.99
Next Earnings Date11/04/2025
Cash Surplus585.8M
Next Ex-Dividend DateUnknown

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation In Our Stock Scanner

As of Sep 12, 2025
example chart graphic
Scan Name: Gravestone DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.